2023 ESC Guidelines for the management of endocarditis: Developed by the task force on the management of endocarditis of the European Society of Cardiology …

V Delgado, N Ajmone Marsan, S de Waha… - European heart …, 2023 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Guidelines for diagnosis and management of infective endocarditis in adults: a WikiGuidelines group consensus statement

EG McDonald, G Aggrey, AT Aslan, M Casias… - JAMA network …, 2023 - jamanetwork.com
Importance Practice guidelines often provide recommendations in which the strength of the
recommendation is dissociated from the quality of the evidence. Objective To create a …

Emerging Treatment Options for Acute Bacterial Skin and Skin Structure Infections and Bloodstream Infections Caused by Staphylococcus aureus: A Comprehensive …

DR Giacobbe, S Dettori, S Corcione… - Infection and drug …, 2022 - Taylor & Francis
Staphylococcus aureus remains an important human pathogen of concern, with mortality
rates surpassing 30% in the case of severe systemic infections. Distinguishing methicillin …

[HTML][HTML] Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

L Herrera-Hidalgo, P Muñoz, A Álvarez-Uría… - International Journal of …, 2023 - Elsevier
Objectives This study aimed to assess the real use of cefazolin for methicillin-susceptible
Staphylococcus aureus (MSSA) infective endocarditis (IE) in the Spanish National …

Therapeutic Options for Adult Patients With Persistent Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Narrative Review

DB Chastain, KL Covert, PJ Tu… - Annals of …, 2023 - journals.sagepub.com
Objective: To compare the efficacy of antimicrobial therapies used in the management of
persistent methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia. Data Sources …

Targeted Therapy of Severe Infections Caused by Staphylococcus aureus in Critically Ill Adult Patients: A Multidisciplinary Proposal of Therapeutic Algorithms Based …

M Gatti, B Viaggi, GM Rossolini, F Pea, P Viale - Microorganisms, 2023 - mdpi.com
(1) Introduction: To develop evidence-based algorithms for targeted antibiotic therapy of
infections caused by Staphylococcus aureus in critically ill adult patients.(2) Methods: A …

Effectiveness and safety of cefazolin versus cloxacillin in endocarditis due to methicillin-susceptible Staphylococcus spp.: a multicenter propensity weighted cohort …

AL Destrem, A Maillard, M Simonet, S Simeon… - European Journal of …, 2024 - Springer
Purpose To compare the effectiveness and safety of cefazolin versus cloxacillin for the
treatment of infective endocarditis (IE) due to methicillin-sensitive Staphylococci (MSS) …

[PDF][PDF] 2023 ESC Guidelines for the management of endocarditis

NA Marsan, S de Waha, N Bonaros, S Caselli… - European Heart …, 2023 - isoic.org
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Staphylococcus aureus endocarditis: Identifying prognostic factors using a method derived from morbidity and mortality conferences

B Lefèvre, A Legoff, M Boutrou, F Goehringer… - Frontiers in …, 2022 - frontiersin.org
Objectives Lethality of Staphylococcus aureus (Sa) infective endocarditis (IE) is high and
might be due to yet unidentified prognostic factors. The aim of this study was to search for …

[HTML][HTML] 儿童感染性心内膜炎的病原学及诊治进展

毛宇娇, 吴晓云 - Advances in Clinical Medicine, 2022 - hanspub.org
小儿感染性心内膜炎多见于有心脏基础疾病的儿童, 是由于病原感染引起的心内膜炎症病变,
可累及全身多系统, 临床表现复杂多样, 早期诊断困难, 住院时间长, 住院花费大 …